PET Imaging, radiochemical synthesis, radiopharma probes

SOFIE Biosciences specializes in the development and distribution of advanced molecular imaging technologies, particularly focusing on theranostic agents that target the tumor stroma. Their flagship technology, Fibroblast Activation Protein Inhibitor (FAPI), is designed to inhibit fibroblast activation protein, a significant target in cancer treatment. This innovative approach has led to the imaging of over 500 patients and has garnered recognition, including the Product/Image/Publication of the Year Award from the Society for Nuclear Medicine and Molecular Imaging. SOFIE's commitment to enhancing patient outcomes is evident in their robust pipeline of next-generation radiopharmaceuticals, which are poised to revolutionize diagnostic and therapeutic practices in oncology.

In addition to their FAPI technology, SOFIE Biosciences offers a comprehensive range of contract manufacturing services through their Theranostics Center of Excellence. They have established a global network of 14 sites dedicated to the timely delivery of radiopharmaceuticals, ensuring that healthcare providers have access to essential diagnostic tools for critical illnesses. Their multi-faceted educational initiatives aim to improve the quality of Positron Emission Tomography (PET) programs, further enhancing patient care. With a strong focus on research and collaboration, SOFIE is positioned to lead advancements in molecular imaging and theranostics, ultimately contributing to better clinical outcomes for patients worldwide.

United States

Our vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With our robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value radiopharmaceutical intellectual property, we are poised to deliver on the promise of radiopharmaceuticals.

www.sofie.com
www.twitter.com/sofiebio
www.instagram.com/sofiebio

SOFIE Biosciences

Company Details